|
Re: MannKind’s Afrezza Likely to Fail AFFINITY 1 Phase III Trial
|
|
Mannkind
|
Apr 11, 2013 03:49PM
|
|
Re: MannKind’s Afrezza Likely to Fail AFFINITY 1 Phase III Trial
|
6
|
Mannkind
|
Apr 11, 2013 04:45PM
|
|
Re: Marijuana Use Linked to Better Diabetes Stats
|
|
Mannkind
|
May 19, 2013 12:36PM
|
|
Re: MARKET CURRENTS
|
|
Mannkind
|
Aug 27, 2012 04:42PM
|
|
Re: Matt just picked up another 1K shares on grant
|
1
|
Mannkind
|
Jan 03, 2013 10:12PM
|
|
Re: Matt's speaking today
|
|
Mannkind
|
Sep 12, 2012 11:28AM
|
|
Re: Matt's speaking today
|
|
Mannkind
|
Sep 12, 2012 11:39AM
|
|
Re: Matt's speaking today
|
1
|
Mannkind
|
Sep 12, 2012 01:10PM
|
|
Re: Matt's speaking today
|
1
|
Mannkind
|
Sep 12, 2012 03:33PM
|
|
Re: Matt's speaking today
|
2
|
Mannkind
|
Sep 12, 2012 04:24PM
|
|
Re: Medtronic takes '1st step' toward U.S. sale of artificial pancreas
|
|
Mannkind
|
Jun 24, 2013 11:30AM
|
|
Re: Medtronic takes '1st step' toward U.S. sale of artificial pancreas
|
|
Mannkind
|
Jun 24, 2013 07:01PM
|
|
Re: Merrill Lynch Picks Diabetes Drug Makers as Real Winners (MRK, BMY, LLY, NOV, MN
|
1
|
Mannkind
|
Mar 27, 2013 11:19AM
|
|
Re: Merrill Lynch Picks Diabetes Drug Makers as Real Winners (MRK, BMY, LLY, NOV, MN
|
|
Mannkind
|
Mar 27, 2013 01:22PM
|
|
Re: Method of preventing adverse effects by GLP-1
|
1
|
Mannkind
|
Feb 19, 2013 01:36PM
|
|
Re: Method of preventing adverse effects by GLP-1
|
1
|
Mannkind
|
Feb 19, 2013 04:00PM
|
|
Re: Michael Higgins on Biotech Names with Major Market Potential
|
1
|
Mannkind
|
Dec 21, 2012 09:16AM
|
|
Re: Michael Higgins on Biotech Names with Major Market Potential
|
|
Mannkind
|
Dec 21, 2012 09:55AM
|
|
Re: MNKD August 23rd Options Begin Trading
|
|
Mannkind
|
Jul 18, 2013 03:30PM
|
|
Re: MNKD Monster Alert from google link...
|
|
Mannkind
|
Mar 28, 2013 11:23AM
|
